Format

Send to

Choose Destination
Nat Rev Drug Discov. 2014 Nov;13(11):795-6. doi: 10.1038/nrd4441.

The international serious adverse events consortium.

Author information

1
iSAEC, 8770 West Bryn Mawr Avenue, Suite 1300, Chicago, Illinois 60631, USA.
2
iSAEC and at the S.J. Quinney College of Law, and Department of Human Genetics, University of Utah, Salt Lake City, Utah 84112, USA.
3
iSAEC Scientific Management Committee and at Pfizer, New London, Connecticut 06320, USA.
4
iSAEC Scientific Management Committee and at GlaxoSmithKline, Research Triangle Park, North Carolina 27709-3398, USA.

Abstract

The International Serious Adverse Events Consortium is generating novel insights into the genetics and biology of drug-induced serious adverse events, and thereby improving pharmaceutical product development and decision-making.

PMID:
25359365
DOI:
10.1038/nrd4441
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center